Gainswave is a non-invasive treatment for erectile dysfunction (ED) that has been used in Europe for almost 20 years. It is based on a series of clinical studies that have demonstrated a success rate of greater than 75% in improving sexual health in men with ED. This therapy is painless, does not involve surgery or medications, and is performed through a simple in-office procedure. Eighty percent of ED in men involves problems with blood flow, making Gainswave one of the most effective therapies available.
In a study of more than 3000 men, the positive response rate was 60% of those available at the end of the study and 48% of those intending to treat. After 12 months, 91.7% of the respondents maintained their answers. The improvements in the IIEF-EF score were greater when erectile dysfunction was more severe, with changes of 13, 10.5, 6.8 and 4.5 points in patients with severe, moderate, mild to moderate and mild erectile dysfunction, respectively. From 3 months after treatment until the end of follow-up monitoring, significant changes were observed in the group of responders for EHS and SEP2 and SEP3, with a response rate of almost 80% of attempts. Gainswave is an effective treatment for ED caused by aging, cardiovascular disease or diabetes.
It has been used successfully for more than 40 high-quality studies and has been proven to be safe and effective with no reported treatment-related adverse events.